Dr Randeep Guleria

The source of avian influenza or H5N1 is mainly poultry animals. "Anyone in close contact with these animals is infected, but human-to-human infections have never been observed," Dr Guleria said.

Any new booster dose should work against current, future Covid strains: Randeep Guleria

"Currently the vaccines that we have in India are covering for what was originally the Wuhan strain. After that we had so many variants. And therefore if we have to have a new vaccine, it should provide cover for the circulating strains like we do for influenza," he said.

XBB.1.16 variant 'new kid on the block', could be driving recent rise in Covid cases: Randeep Guleria

New variants will keep coming as the virus keeps on mutating over the time and the XBB 1.16 is sort of a "new kid on the block", Guleria said.

AIIMS director Randeep Guleria gets another 3-months extension

According to an official document released by AIIMS hospital on Thursday, Dr. Randeep Guleria's term as director of AIIMS New Delhi has been extended by an additional three months.

COVID-19 vaccines can be tweaked for protection against new variants: AIIMS director Dr Randeep Guleria

Dr Randeep Guleria remarks have come in the wake of concerns over the new Omicron variant of COVID-19.

Delhi oxygen row: Can't say demand was inflated by four times, says AIIMS chief who led audit

The Delhi oxygen audit is an interim report, and a final report is awaited, Dr Randeep Guleria said, adding that the matter is currently in the Supreme Court.

COVID-19 vaccine for children: Covaxin approval expected by October, says AIIMS Chief Randeep Guleria

AIIMS Chief Randeep Guleria further said that the Covaxin "covers a wide spectrum" as Bharat Biotech is conducting trials between the age group of 2 to 18 years.

COVID-19 third wave inevitable, could strike India in 6-8 weeks: AIIMS chief

The arrival of the third wave could be expedited through the violation of COVID-appropriate behaviour, Dr Randeep Guleria said.

COVID-19 vaccine | India needs to ramp up production to inoculate one crore people a day, says AIIMS chief

The need to boost vaccine production, as stated by AIIMS chief Dr Randeep Guleria, comes in the backdrop of several states reporting a shortage in vaccine supply that has hindered their respective inoculation programmes.

Black Fungus | Use steroids judiciously to prevent mucormycosis, says AIIMS Director Dr Randeep Guleria

Good control and regular monitoring of blood sugar levels of those on steroids is also important, Dr Guleria has said.

Amid COVID-19 second wave, experts suggest 'double masking' to minimise virus exposure

Recent studies conducted by the US Centre for Disease Control and Prevention (CDC) found that double masking could minimise the risk of virus exposure by up to 95.9 percent.

Non-adherence to COVID-19 norms, virulent strains could be behind surge in infections: AIIMS chief

AIIMS Director Dr Randeep Guleria also warned that if the situation is not reversed, then the galloping infection rate will eventually cause a huge strain on the country's healthcare system. He sought stricter enforcement of COVID-appropriate behaviour on the ground level by the administration and authorities.

COVID-19 | Achieving herd immunity difficult, new strains could cause reinfection: AIIMS chief

The mutated version of coronavirus could 'escape' through the immune system developed by the body. In such a scenario, maintaining COVID-19-approporiate behaviour is of utmost necessity to reduce the pace of transmission, said Dr Randeep Guleria.